{"id":22889,"date":"2026-05-18T11:27:54","date_gmt":"2026-05-18T11:27:54","guid":{"rendered":"https:\/\/engineerbabu.com\/blog\/?p=22889"},"modified":"2026-05-18T11:27:54","modified_gmt":"2026-05-18T11:27:54","slug":"how-ai-prior-authorization-works-in-the-usa","status":"publish","type":"post","link":"https:\/\/engineerbabu.com\/blog\/how-ai-prior-authorization-works-in-the-usa\/","title":{"rendered":"How AI Prior Authorization Works in the USA: What’s Actually Happening in 2026"},"content":{"rendered":"

The <\/span>American Medical Association<\/span><\/a> published a survey two days ago. One number stopped me mid-scroll.<\/span><\/p>\n

26% of US physicians report that prior authorization has led to a serious adverse event for a patient, including hospitalization, permanent impairment, or death.<\/span><\/p>\n

No delays. Not an inconvenience. Permanent impairment and death.<\/span><\/p>\n

Meanwhile, investigative reporting uncovered that one large US payer’s AI algorithm rejected 300,000 claims over two months, one every 1.2 seconds. A human reviewing each claim for 30 seconds would need more than 100 days of continuous work to match that volume.<\/span><\/p>\n

This is the collision point US healthcare is navigating in 2026: AI being deployed by payers to deny faster, AI being deployed by providers to approve faster and a regulatory structure still trying to determine who is liable when an algorithm makes the wrong call.<\/span><\/p>\n

I’m Mayank Pratap, co-founder of <\/span>EngineerBabu<\/span><\/a>, a CMMI Level 5, Google AI Accelerator team that has built <\/span>healthcare AI products<\/span><\/a> for clients including Apollo Hospitals, ResMed, and US-based digital health startups.<\/span><\/p>\n

We’ve built prior authorization automation platforms, AI clinical documentation systems, and EHR-integrated workflows. This is what AI prior authorization actually looks like in production in 2026, from both the policy and the engineering perspective.<\/span><\/p>\n

What Is AI Prior Authorization?<\/b><\/h2>\n

AI prior authorization is the use of <\/span>artificial intelligence<\/span><\/a>, natural language processing, <\/span>machine learning<\/span><\/a>, and large language models to automate the process of requesting and reviewing insurance coverage approval before a medical service, procedure, or medication is delivered.<\/span><\/p>\n

On the provider side, AI reads the patient’s EHR, extracts relevant clinical documentation, maps it against payer-specific criteria, and submits the request electronically without manual staff intervention.<\/span><\/p>\n

On the payer side, AI screens incoming requests against clinical guidelines and coverage policies to approve or flag for human review. Both sides are now operating in the same regulatory environment: CMS’s Interoperability and Prior Authorization Final Rule (CMS-0057), effective 2026\u20132027.<\/span><\/p>\n

The Crisis That Made AI Prior Authorization Inevitable<\/b><\/h2>\n

Prior authorization was designed as a cost-control mechanism. What it became is a documented source of patient harm and physician burnout.<\/span><\/p>\n

The AMA’s May 2026 survey of 1,000 practicing physicians published this week shows how little has changed despite years of insurer pledges:<\/span><\/p>\n